GLP-1 RAs improve glycaemic control through glucose-dependent insulin secretion, glucagon suppression, slowed gastric emptying, and enhanced satiety, yielding HbA1c reductions, weight loss, and cardiovascular benefits in type 2 diabetes. This evidence concerns the gene GCG and type 2 diabetes mellitus.